Business NewsNews

MEDTRONIC COMPLETES ACQUISITION OF MAZOR ROBOTICS

Medtronic plc   completed the acquisition of Israel-based Mazor Robotics Dec. 19.

Under the terms of the acquisition agreement, Mazor shareholders will receive $58.50 per ADS, or $29.25 per ordinary share, in cash. The total value of the transaction is reported at $1.7B, or $1.3B net of Medtronic’s existing stake in Mazor and cash acquired.

Mazor Robotics joins Medtronic’s Neurosurgery business, which is part of the Restorative Therapies Group’s Brain Therapies division. VTN

 

Previous post

MERIT MEDICAL ACQUIRES ASSETS OF VASCULAR INSIGHTS DEC 17

Next post

MCAFEE: CRYPTOMINING AND IoT MALWARE BOTH ROSE OVER 70% IN Q3 2018

Larry Storer

Larry Storer

Larry Storer has been editor of Vein Therapy News for 10 years. He has edited computer, shelter and medical publications at Publications & Communications LP for 30 years. He was also a corporate vice president and editorial director before retiring. Larry graduated from Baylor University with a BA in journalism and an MA in communications; and from Lamar University with a MED in school administration. He taught beginning and advanced reporting, beginning and advanced editing and editorial writing at Baylor University. Larry was a reporter, and city and news editor of the Beaumont Journal, and opinion editor at the Beaumont Enterprise and Beaumont Enterprise-Journal. He was also the founding managing editor of the Yuba City (California) Daily Independent-Herald.